Publications by authors named "Lydia Reinhardt"

Claim this Profile
O
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.
Selma Ugurel, Nessr Abu Rached, Thilo Gambichler, Miriam Mengoni, Thomas Tüting, Lydia Reinhardt

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma.
Georg C Lodde, Jessica C Hassel, Imke von Wasielewski, Friedegund Meier, Peter Mohr, Lydia Reinhardt

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMP, MEK, and WNT inhibition with NGN2 expression for rapid generation of hiPSC-derived neurons amenable to regional patterning.
Carina Habich, Alexandra Kowalski, Astrid Wachter, Michaela J Heimann, Michael Wolf, Lydia Reinhardt, Peter Reinhardt

Stem Cell Reports· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General practitioners' perspectives on statutory skin cancer screening-A questionnaire-based cross-sectional survey in Germany.
Lydia Reinhardt, Cristin Strasser, Theresa Steeb, Anne Petzold, Markus V Heppt

PLoS One· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors.
Theresa Ruf, Rafaela Kramer, Andrea Forschner, Ulrike Leiter, Friedegund Meier, Lydia Reinhardt

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a high-content imaging assay for tau aggregation in hiPSC-derived neurons differentiated from two protocols to routinely evaluate compounds and genetic perturbations.
Lamiaa Bahnassawy, Nathalie Nicolaisen, Christopher Untucht, Benjamin Mielich-Süss, Lydia Reinhardt, Peter Reinhardt

SLAS Discov· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
Nikolaus B Wagner, Max M Lenders, Kathrin Kühl, Lydia Reinhardt, Milena Fuchß

Eur J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axonal Lysosomal Assays for Characterizing the Effects of LRRK2 G2019S.
Priyanka Bhatia, Marc Bickle, Amay A Agrawal, Buster Truss, Aikaterina Nikolaidi, Lydia Reinhardt

Biology (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality, Understandability and Reliability of YouTube Videos on Skin Cancer Screening.
Lydia Reinhardt, Theresa Steeb, Anika Mifka, Carola Berking, Friedegund Meier

J Cancer Educ· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study.
Georg C Lodde, Jessica Hassel, Lena M Wulfken, Friedegund Meier, Peter Mohr, Lydia Reinhardt

Eur J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One Website to Gather them All: Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website-A Mixed-methods Approach.
Theresa Steeb, Julia Brütting, Lydia Reinhardt, Julia Hoffmann, Nina Weiler

J Cancer Educ· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raising awareness of immune-related side effects in oncological patients under palliative care: a report of two cases.
Anne Strunk, Yann-Nicolas Batzler, Mirjana Ziemer, Martin Neukirchen, Jacqueline Schwartz, Lydia Reinhardt

Ann Palliat Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual truncation of tau by caspase-2 accelerates its CHIP-mediated degradation.
Lydia Reinhardt, Fabrizio Musacchio, Maria Bichmann, Annika Behrendt, Ebru Ercan-Herbst, Peter Reinhardt

Neurobiol Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
Katharina Schumann, Cornelia Mauch, Kai-Christian Klespe, Carmen Loquai, Ulrike Nikfarjam, Lydia Reinhardt

J Eur Acad Dermatol Venereol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, Wolfgang Boehmerle, Petra Huehnchen, Lydia Reinhardt

Data Brief· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are YouTube videos on cutaneous squamous cell carcinoma a useful and reliable source for patients?
Lydia Reinhardt, Theresa Steeb, Matthias Harlaß, Julia Brütting, Friedegund Meier

J Dtsch Dermatol Ges· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sind YouTube-Videos zum kutanen Plattenepithelkarzinom nützliche und zuverlässige Informationsquellen für Patienten?
Lydia Reinhardt, Theresa Steeb, Matthias Harlaß, Julia Brütting, Friedegund Meier

J Dtsch Dermatol Ges· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, Wolfgang Boehmerle, Petra Huehnchen, Lydia Reinhardt

Eur J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.
Georg C Lodde, Philipp Jansen, Inga Möller, Antje Sucker, Jessica C Hassel, Lydia Reinhardt

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Qualitative Needs Analysis of Skin Cancer Care from the Perspectives of Patients, Physicians, and Health Insurance Representatives-A Case Study from Eastern Saxony, Germany.
Josephine Mathiebe, Lydia Reinhardt, Maike Bergmann, Marina Lindauer, Alina Herrmann

Curr Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Quality, Understandability, and Reliability of YouTube Videos as a Source of Information on Basal Cell Carcinoma: Web-Based Analysis.
Theresa Steeb, Lydia Reinhardt, Matthias Harlaß, Markus Vincent Heppt, Friedegund Meier

JMIR Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis.
Anne Zaremba, Rafaela Kramer, Viola De Temple, Stefanie Bertram, Martin Salzmann, Lydia Reinhardt

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.
Anne Zaremba, Manuel Philip, Jessica C Hassel, Valerie Glutsch, Zeno Fiocco, Lydia Reinhardt

Eur J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients.
Georg Lodde, Andrea Forschner, Jessica Hassel, Lena M Wulfken, Friedegund Meier, Lydia Reinhardt

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study.
Katharina C Kähler, Ralf Gutzmer, Friedegrund Meier, Lisa Zimmer, Markus Heppt, Lydia Reinhardt

Front Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis